Analyst Price Targets — LLY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 14, 2026 10:20 am | — | Bernstein | $1,385.00 | $1,185.08 | StreetInsider | Eli Lilly (LLY) PT Raised to $1,385 at Bernstein SocGen GroupMember Login |
| July 13, 2026 2:01 pm | — | UBS | $1,425.00 | $1,189.91 | TheFly | Eli Lilly price target raised to $1,425 from $1,250 at UBS |
| July 13, 2026 10:51 am | — | Guggenheim | $1,273.00 | $1,188.58 | StreetInsider | Eli Lilly (LLY) PT Raised to $1,273 at GuggenheimMember Login |
| July 9, 2026 12:29 pm | — | UBS | $1,370.00 | $1,222.13 | TheFly | Eli Lilly price target raised to $1,370 from $1,281 at Truist |
| July 8, 2026 12:52 pm | — | Truist Financial | $1,370.00 | $1,227.07 | StreetInsider | Eli Lilly (LLY) PT Raised to $1,370 at Truist SecuritiesMember Login |
| July 8, 2026 11:59 am | — | RBC Capital | $1,500.00 | $1,229.22 | TheFly | Eli Lilly price target raised to $1,500 from $1,250 at RBC Capital |
| July 8, 2026 11:37 am | Terence Flynn | Morgan Stanley | $1,347.00 | $1,235.56 | TheFly | Eli Lilly price target raised to $1,347 from $1,344 at Morgan Stanley |
| July 6, 2026 10:45 am | — | Cantor Fitzgerald | $1,350.00 | $1,210.50 | StreetInsider | Eli Lilly (LLY) PT Raised to $1,350 at Cantor Fitzgerald as Strong Q2 Results LikelyMember Login |
| June 25, 2026 10:02 am | David Risinger | Leerink Partners | $1,232.00 | $1,117.26 | TheFly | Eli Lilly price target raised to $1,232 from $1,119 at Leerink |
| June 22, 2026 3:48 pm | Kerry Holford | Berenberg Bank | $1,135.00 | $1,111.67 | TheFly | Eli Lilly price target raised to $1,135 from $1,050 at Berenberg |
Latest News for LLY
I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics, and inflation while generating attractive income. My "ALLKA Dividend Rating" model separates quality dividend opportunities from yield traps by analyzing dividend sustainability, growth prospects, and valuation. The article explores three dividend strategies, "High-Yield Defensive," "Balanced Income," and "Pure…
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AtaiBeckley Inc. (NasdaqGM: ATAI) to Eli Lilly and Company (NYSE: LLY). Under the terms of the proposed transaction, shareholders of AtaiBeckley will receive $6.75 per share in cash, plus up to $2.50 per share in the form of…
Lulu's Fashion Lounge Holdings (NASDAQ:LVLU) retained Solomon Partners as its financial advisor and Willkie Farr & Gallagher LLP as its legal advisor as the company evaluates strategic alternatives to maximize shareholder value. Alternatives may include a potential transaction or continued execution of Lulu's standalone strategic plan.
Sector leader Eli Lilly is in a buy zone above a pivot at 1,133.95 ahead of second-quarter results, due on Aug. 5.
LLY agrees to acquire AtaiBeckley for $2.8B upfront to expand its neuroscience pipeline with psychedelic therapies for mental health disorders.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.